Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Scinai Immunotherapeutics Ltd. for Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Scinai Immunotherapeutics Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate for Q4 2024.
  • Scinai Immunotherapeutics Ltd. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2024 was $384,000.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Scinai Immunotherapeutics Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $384,000 31 Dec 2024 20-F 07 May 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.